Oniadba Nail Fungus Treatment Pen Liquid
NDC Package 85992-004-01
Package Information
Oniadba Nail Fungus Treatment Pen (tolnaftate, undecylenic acid) liquids is antifungal treatment for fingernails, toenails, and surrounding skin.Effective against fungal nails.athlete's foot, tinea manuum, and ringworm caused by fungi.Addresses nail fungus,discoloration, thickening, splitting, and crumbling. This formulation utilizes a liquid delivery system. Marketed by Shenzhen Boyimei Technology Co., Ltd., this product is identified by NDC 85992-004 and is authorized under FDA application M005.
Identification & Billing
- RxCUI: 2691548 - tolnaftate 1 % / undecylenic acid 25 % Topical Solution
- RxCUI: 2691548 - tolnaftate 10 MG/ML / undecylenic acid 250 MG/ML Topical Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 85992 - Shenzhen Boyimei Technology Co., Ltd.
- 85992-004 - Oniadba Nail Fungus Treatment Pen
- 85992-004-01 - 4 TUBE, WITH APPLICATOR in 1 BOX / 5 mL in 1 TUBE, WITH APPLICATOR
- 85992-004 - Oniadba Nail Fungus Treatment Pen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85992-004-01 identifies a specific commercial package of 4 tube, with applicator in 1 box / 5 ml in 1 tube, with applicator of Oniadba Nail Fungus Treatment Pen, a human over the counter drug labeled by Shenzhen Boyimei Technology Co., Ltd.. This liquid is formulated for topical use and contains tolnaftate; undecylenic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shenzhen Boyimei Technology Co., Ltd. on August 06, 2025. The current certification is valid through December 31, 2026.
How is this Shenzhen Boyimei Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85992000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.